ReviewCardiovascular endocrinology & metabolism2021

JAK out of the Box; The Rationale behind Janus Kinase Inhibitors in the COVID-19 setting, and their potential in obese and diabetic populations.

Rahma Menshawey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.